Abstract LB-309: the Heparan Sulfate Mimetic PG545 Increases Plasma VEGF and FGF-2 in Advanced Cancer Patients, and Significantly Inhibits Tumor Growth in Preclinical Models of Ovarian Cancer - Implications for Future Therapy